Get started
Author

Annette Weiser

Central nervous system tumors in children under 5 years of age: a report on treatment burden, survival and long-term outcomes
2022 · Sarah Metzger, Annette Weiser, et al. · Journal of Neuro-Oncology · 17
PDF
MSH2, MSH6, MLH1, and PMS2 immunohistochemistry as highly sensitive screening method for DNA mismatch repair deficiency syndromes in pediatric high-grade glioma
2025 · Lea L. Friker, Thomas Perwein, et al. · Acta Neuropathologica · 14
PDF
Bridging the age gap: a review of molecularly informed treatments for glioma in adolescents and young adults
2023 · Annette Weiser, Astrid Sanchez Bergman, et al. · Frontiers in Oncology · 14
Treatment of Medulloblastoma in the Adolescent and Young Adult Population: A Systematic Review
2024 · Maria Otth, Annette Weiser, et al. · Journal of Adolescent and Young Adult Oncology · 4
PDF
An exceptionally rare case of a diffuse midline glioma with concomitant H3.1 K27M and G34R mutations in the HIST1H3C (H3C3) gene
2025 · Zita Reisz, Rita Pereira, et al. · Acta Neuropathologica Communications · 3
PDF
Treatment of NF1-Associated Optic Pathway/Hypothalamic Gliomas in Patients With Diencephalic Syndrome
2022 · Annette Weiser, Heinz Hengartner, et al. · Journal of Pediatric Hematology/Oncology · 2
ID #405 IDH mutated low grade glioma in childhood and the impact of early inhibitor use: an international registry study
2026 · Juhi Mehrotra, Marina Caballero Bellon, et al. · Neuro-Oncology Pediatrics · 1
Central Nervous System Metastases from Pediatric Solid Tumors: A Single-Institution Study
2026 · Nina Gauthier, Annette Weiser, et al. · World Neurosurgery · 1
Integrated clinical and molecular landscape of disseminated pediatric low-grade glioma
2025 · Adrian B Levine, Julie Bennett, et al. · Neuro-Oncology · 1
Hgg-26. Mlh1, Msh2, Msh6, and Pms2 Immunohistochemistry Represents a Highly Sensitive Screening Method for Mismatch Repair Deficiency Syndromes in Pediatric High-grade Glioma
2024 · Lea L Friker, Thomas Perwein, et al. · Neuro-Oncology · 1
PDF
Lgg-47. Vinblastine to Prevent Tumour Rebound After Bevacizumab/irinotecan in Children and Adolescents With Multiply Relapsed Low-grade Gliomas: the South London Paediatric & Tya Neuro-oncology Network Experience
2024 · Annette Weiser, Julia V Cockle, et al. · Neuro-Oncology · 1
PDF
Dipg-53. an Exceptionally Rare Case of a Diffuse Midline Glioma With Concomitant H3.1 K27m and G34r Mutations in Thehist1h3c (h3c3) Gene
2024 · Zita Reisz, Rita Pereira, et al. · Neuro-Oncology · 1
PDF
Correction to: Central nervous system tumors in children under 5 years of age: a report on treatment burden, survival and long-term outcomes
2022 · Sarah Metzger, Annette Weiser, et al. · Journal of Neuro-Oncology · 1
PDF
ID #82 Molecular and Cellular Diversity in Pediatric Low-Grade Glioma: Insights from Matched Primary / Recurrent Samples.
2026 · Charbel Machaalani, Annette Weiser, et al. · Neuro-Oncology Pediatrics
Disseminated pediatric low-grade glioma and hydrocephalus: a multinational consortium analysis of incidence and mortality
2025 · Alexander T. Lyons, Joseline Haizel-Cobbina, et al. · Journal of Neurosurgery Pediatrics
Lgg-12. Integrated Clinical and Molecular Characterization of 200 Disseminated Pediatric Low-grade Gliomas
2024 · Adrian Levine, Julie Bennett, et al. · Neuro-Oncology
Works count: 17
Citation count: 61
H-index: 4
I10-index: 3
Year
Topic
Type